Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy
Christian Ljørring
Allergy, 2011
View PDFchevron_right
Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
Franco Frati
Clinical and Molecular Allergy, 2012
View PDFchevron_right
Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome
Wolf-Meinhard Becker
Clinical & Experimental Allergy, 1999
View PDFchevron_right
Effect of grass pollen immunotherapy on clinical and local immune response to nasal allergen challenge
Deborah Phippard
Allergy, 2015
View PDFchevron_right
Immunologic Effects and Tolerability Profile of In-Season Initiation of a Standardized-Quality Grass Allergy Immunotherapy Tablet: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial in Adults with Grass Pollen–Induced Rhinoconjunctivitis
Hanne Villesen
Clinical Therapeutics, 2011
View PDFchevron_right
Intradermal grass pollen immunotherapy increases T H 2 and IgE responses and worsens respiratory allergic symptoms
Rachel Muir
Journal of Allergy and Clinical Immunology, 2017
View PDFchevron_right
Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis☆☆☆★
Isaak Effendy
Journal of Allergy and Clinical Immunology, 1997
View PDFchevron_right
Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires
Sabina Rak
Clinical and Translational Allergy
View PDFchevron_right
T cell response to grass pollen allergens: Correlation with skin test reactivity and serum IgE levels
James McCluskey
Immunology and Cell Biology, 1995
View PDFchevron_right
Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy
Jodi Suryanggono
View PDFchevron_right
Pre-treatment allergen-specific IgE analysis and outcomes of allergen immunotherapy
Svante Hugosson
European Annals of Allergy and Clinical Immunology, 2021
View PDFchevron_right
Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model
Georges Choufani
Clinical & Experimental Allergy, 1999
View PDFchevron_right
Grass pollen immunotherapy: A single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis
giovanni joppolo
Journal of Allergy and Clinical Immunology, 1984
View PDFchevron_right
Complex diagnosis of IgE mediated allergy by in vivo and in vitro methods
A. Michova
World Allergy Organization Journal, 2007
View PDFchevron_right
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber
Michel Melac
Journal of Allergy and Clinical Immunology, 2009
View PDFchevron_right
Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Glenis Scadding
Journal of Allergy and Clinical Immunology, 2010
View PDFchevron_right
Intradermal Grass Pollen Allergen Immunotherapy for Seasonal Allergy: A Randomized Controlled Trial
Janet Peacock
Journal of Allergy and Clinical Immunology, 2016
View PDFchevron_right
Allergenicity, immunogenicity and dose-relationship of three intact allergen vaccines and four allergoid vaccines for subcutaneous grass pollen immunotherapy
Helene Henmar
Clinical & Experimental Immunology, 2008
View PDFchevron_right
Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells
Guy Scadding, Mohamed Shamji
Clinical & Experimental Allergy, 2010
View PDFchevron_right
Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
Giampiero Patriarca
Clinical & Experimental Allergy, 2009
View PDFchevron_right
The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children
W. Kamin, Eckard Hamelmann
Allergy, 2004
View PDFchevron_right
Conversion of grass pollen allergen-specific human IgE into a protective IgG1 antibody
Peter Steinberger
European Journal of Immunology, 2002
View PDFchevron_right
Grass Pollen Immunotherapy Induces an Allergen-Specific IgA2 Antibody Response Associated with Mucosal TGF- Expression
Charles Pilette
The Journal of Immunology, 2007
View PDFchevron_right
Grass Pollen Immunotherapy: Impaired Allergen-Induced Nasal and Cutaneous Responses Correlate With Overall Seasonal Symptom Scores and Are Associated With Suppressed Local Th2 Cytokines In Nasal Fluid
Deborah Phippard
Journal of Allergy and Clinical Immunology, 2014
View PDFchevron_right
A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma
Martin Pedersen
Journal of Negative Results in BioMedicine, 2013
View PDFchevron_right
Association of allergic patients’ phenotypes with IgE reactivity to recombinant pollen marker allergens
Ines Swoboda
Allergy, 2010
View PDFchevron_right
Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial
Samantha Walker
Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, 2002
View PDFchevron_right
Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapy
Salvatore Tripodi
Journal of Allergy and Clinical Immunology, 2012
View PDFchevron_right
The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis
Cansin Saçkesen
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2006
View PDFchevron_right
Functional immunoglobulin E cross-reactivity between Pas n 1 of Bahia grass pollen and other group 1 grass pollen allergens
Thanh Nguyen Huynh dang
Clinical & Experimental Allergy, 2011
View PDFchevron_right
Allergen-reactive antibodies are found in nasal fluids from patients with birch pollen-induced intermittent allergic rhinitis, but not in healthy controls
Mikael Benson
Allergy, 2003
View PDFchevron_right
Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy
P. Moingeon
Allergy, 2011
View PDFchevron_right
Comparison of perennial and preseasonal allergoid immunotherapy in grass pollen allergic patients
münevver pınar
Asian Pacific Journal of Allergy and Immunology, 2021
View PDFchevron_right